Data_Sheet_2_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

“…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. Linear regression analyses showed that increased CPV and decreased DTI-ALPS index were independent risk factors for semantic fluency impairment (all p < 0.05). …”

Table_2_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

“…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. Linear regression analyses showed that increased CPV and decreased DTI-ALPS index were independent risk factors for semantic fluency impairment (all p < 0.05). …”

Table_3_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

“…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. Linear regression analyses showed that increased CPV and decreased DTI-ALPS index were independent risk factors for semantic fluency impairment (all p < 0.05). …”

Table_1_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

“…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. Linear regression analyses showed that increased CPV and decreased DTI-ALPS index were independent risk factors for semantic fluency impairment (all p < 0.05). …”

Data_Sheet_1_Association of glymphatic system dysfunction with cognitive impairment in temporal lobe epilepsy.docx by Jiajia Wang (157207)

“…Correlation analyses found that SVF performance was significantly or borderline significantly associated with glymphatic function (FDR-corrected p < 0.05 for all DTI-ALPS index and FDR-corrected p = 0.057 for CPV) in TLE patients. Linear regression analyses showed that increased CPV and decreased DTI-ALPS index were independent risk factors for semantic fluency impairment (all p < 0.05). …”

PVD neurons show reduced lysosome function during aging and in the <i>hlh-30</i> mutant. by Ruiling Zhong (22339779)

“…<p><b>(A–D)</b> A fluorescent reporter for luminal acidity of neuronal lysosomal compartments shows that acidity decreases with aging and in the <i><i>hlh-30</i></i> mutant. …”

Image 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Table 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 2_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 11_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 7_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 8_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 6_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 4_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 9_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 12_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.jpeg by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Table 3_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Image 13_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.tiff by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”

Table 1_No change in key HIV target cell markers following initiation of three progestin-based hormonal contraception methods: findings from the CHIME study.docx by Marisa R. Young (7919255)

“…Observational studies, but not a randomized trial, suggest increased risk of HIV acquisition with HC use, particularly DMPA. …”